Skip to content
DataLookout
Start free
Menu

ENGAGENCT07793396

Prospective Study of Eslicarbazepine in Adults With Focal-Onset Seizures

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 1 of 2 entries
    • Study description expanded, about 6 words
    v2
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change in Seizure Frequency
Timeframe: From Baseline to Month 3
Seizure Response Rate
Timeframe: From Baseline to Month 3

Secondary (2)

Change in QOLIE-10-P Score
Adverse Events and Serious Adverse Events

Arms and interventions

Newly Diagnosed / Treatment-Naïve

Adults with diagnosed focal-onset seizures who are newly diagnosed/treatment-naïve and receive eslicarbazepine as part of routine clinical care.

Previously Treated With Carbamazepine/Oxcarbazepine

Adults with focal-onset seizures previously treated with carbamazepine or oxcarbazepine who have inadequate seizure control or intolerable adverse effects and receive eslicarbazepine as part of routine clinical care.

Drugs: Eslicarbazepine acetate

Sites

1 site in 1 country

  • Mayo Hospital LahoreLahore, Punjab Province, Pakistan